Best TWAS P=4.53e-13 · Best GWAS P=7.55e-12 conditioned to 1
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | SMAD9 | 0.25 | 0.16 | lasso | 8 | 0.16 | 1.2e-18 | 5.9 | 6.0 | 2.3e-09 | 0.01 | 0.46 | 0.54 | FALSE |
2 | GTEx | Liver | SPG20 | 0.24 | 0.04 | lasso | 4 | 0.05 | 1.6e-02 | -4.9 | 5.4 | 5.7e-08 | -0.67 | 0.06 | 0.56 | FALSE |
3 | GTEx | Nerve Tibial | SMAD9 | 0.16 | 0.11 | enet | 22 | 0.15 | 1.0e-10 | 6.0 | 6.5 | 8.9e-11 | -0.09 | 0.43 | 0.55 | FALSE |
4 | GTEx | Pancreas | SPG20 | 0.27 | 0.11 | lasso | 4 | 0.06 | 1.3e-03 | -6.8 | 7.2 | 4.5e-13 | -0.96 | 0.01 | 0.98 | TRUE |
5 | GTEx | Whole Blood | SPG20 | 0.09 | 0.02 | enet | 30 | 0.00 | 1.5e-01 | -6.6 | -6.7 | 2.0e-11 | 0.77 | 0.02 | 0.96 | FALSE |
6 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C13orf38 | 0.04 | 0.02 | lasso | 4 | 0.03 | 2.0e-07 | -6.0 | -6.0 | 2.5e-09 | 0.82 | 0.01 | 0.99 | FALSE |
7 | The Cancer Genome Atlas | Breast Invasive Carcinoma | SMAD9 | 0.06 | 0.02 | enet | 9 | 0.03 | 5.2e-07 | 5.9 | 6.8 | 8.4e-12 | 0.03 | 0.00 | 1.00 | TRUE |
8 | The Cancer Genome Atlas | Breast Invasive Carcinoma | SOHLH2 | 0.13 | 0.19 | lasso | 13 | 0.22 | 1.7e-43 | -4.9 | -6.4 | 1.8e-10 | 0.76 | 0.97 | 0.03 | FALSE |
9 | The Cancer Genome Atlas | Breast Invasive Carcinoma | SPG20 | 0.02 | 0.01 | enet | 7 | 0.01 | 2.0e-02 | 3.4 | -5.7 | 1.0e-08 | 0.65 | 0.05 | 0.46 | FALSE |
10 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | SOHLH2 | 0.11 | 0.14 | enet | 19 | 0.11 | 5.7e-06 | -4.8 | -6.2 | 7.7e-10 | 0.64 | 0.17 | 0.82 | FALSE |
11 | The Cancer Genome Atlas | Glioblastoma Multiforme | SOHLH2 | 0.35 | 0.28 | blup | 105 | 0.27 | 8.3e-09 | -4.9 | -6.5 | 8.0e-11 | 0.68 | 0.57 | 0.42 | FALSE |
12 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | SOHLH2 | 0.11 | 0.18 | enet | 12 | 0.19 | 2.0e-21 | -4.8 | -6.2 | 4.6e-10 | 0.73 | 0.96 | 0.04 | FALSE |
13 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | SOHLH2 | 0.27 | 0.29 | enet | 22 | 0.30 | 8.4e-18 | -4.9 | -5.9 | 3.9e-09 | 0.59 | 0.99 | 0.01 | FALSE |
14 | The Cancer Genome Atlas | Brain Lower Grade Glioma | C13orf38 | 0.06 | 0.04 | lasso | 2 | 0.04 | 2.2e-05 | -6.0 | -6.0 | 2.0e-09 | 0.89 | 0.01 | 0.97 | FALSE |
15 | The Cancer Genome Atlas | Brain Lower Grade Glioma | SMAD9 | 0.08 | 0.03 | enet | 6 | 0.05 | 2.9e-06 | 5.9 | 6.7 | 2.5e-11 | 0.04 | 0.00 | 1.00 | FALSE |
16 | The Cancer Genome Atlas | Brain Lower Grade Glioma | SOHLH2 | 0.25 | 0.41 | enet | 20 | 0.42 | 4.7e-52 | -4.8 | -6.0 | 1.5e-09 | 0.68 | 1.00 | 0.00 | FALSE |
17 | The Cancer Genome Atlas | Lung Adenocarcinoma | C13orf38 | 0.08 | 0.03 | blup | 66 | 0.06 | 4.9e-08 | 2.5 | -5.6 | 1.7e-08 | 0.69 | 0.06 | 0.93 | FALSE |
18 | The Cancer Genome Atlas | Lung Adenocarcinoma | SOHLH2 | 0.10 | 0.15 | lasso | 3 | 0.16 | 5.8e-18 | -4.8 | -5.7 | 1.5e-08 | 0.60 | 0.99 | 0.01 | FALSE |
19 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | SOHLH2 | 0.14 | 0.10 | lasso | 4 | 0.15 | 3.9e-10 | -4.8 | -5.7 | 1.1e-08 | 0.72 | 0.24 | 0.76 | FALSE |
20 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | SOHLH2 | 0.09 | 0.14 | lasso | 2 | 0.11 | 2.4e-05 | -4.8 | -5.1 | 2.8e-07 | 0.49 | 0.45 | 0.24 | FALSE |
21 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | C13orf38 | 0.11 | 0.02 | blup | 66 | 0.07 | 1.1e-03 | -6.7 | -6.8 | 1.2e-11 | 0.83 | 0.01 | 0.96 | FALSE |
22 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | SOHLH2 | 0.23 | 0.15 | blup | 105 | 0.21 | 5.8e-09 | -4.9 | -6.1 | 8.5e-10 | 0.74 | 0.05 | 0.95 | FALSE |
23 | The Cancer Genome Atlas | Prostate Adenocarcinoma | C13orf38 | 0.15 | 0.17 | lasso | 3 | 0.17 | 1.8e-17 | -6.6 | -6.2 | 5.5e-10 | 0.91 | 0.01 | 0.99 | FALSE |
24 | The Cancer Genome Atlas | Prostate Adenocarcinoma | SOHLH2 | 0.24 | 0.33 | lasso | 10 | 0.36 | 2.6e-39 | -6.6 | -6.7 | 2.1e-11 | 0.85 | 0.01 | 0.99 | FALSE |
25 | The Cancer Genome Atlas | Prostate Adenocarcinoma | SPG20 | 0.04 | 0.00 | blup | 74 | 0.02 | 3.0e-03 | -4.8 | 6.6 | 3.6e-11 | -0.79 | 0.02 | 0.45 | FALSE |
26 | The Cancer Genome Atlas | Rectum Adenocarcinoma | SOHLH2 | 0.16 | 0.05 | blup | 105 | 0.03 | 6.3e-02 | 4.4 | -6.4 | 1.8e-10 | 0.66 | 0.03 | 0.52 | FALSE |
27 | The Cancer Genome Atlas | Rectum Adenocarcinoma | SPG20 | 0.17 | 0.15 | lasso | 8 | 0.13 | 6.7e-04 | -6.0 | 6.3 | 3.8e-10 | -0.92 | 0.02 | 0.88 | FALSE |
28 | The Cancer Genome Atlas | Soft Tissue Sarcoma | SOHLH2 | 0.16 | 0.08 | enet | 21 | 0.15 | 1.7e-09 | -4.8 | -5.6 | 1.7e-08 | 0.56 | 0.16 | 0.83 | FALSE |
29 | The Cancer Genome Atlas | Thyroid Carcinoma | C13orf38 | 0.10 | 0.07 | lasso | 4 | 0.10 | 3.9e-10 | -6.5 | -6.7 | 2.4e-11 | 0.84 | 0.02 | 0.98 | FALSE |
30 | The Cancer Genome Atlas | Thyroid Carcinoma | SOHLH2 | 0.32 | 0.39 | enet | 33 | 0.43 | 6.0e-46 | -4.9 | -6.1 | 1.2e-09 | 0.72 | 1.00 | 0.00 | FALSE |